Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | PNP | P00491 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | PDE4A | P27815 | 1/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.42 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.42 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.42 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL28768404 | 0.92 | EIF4E (0.46) | GDACYP3A4PMP22MAPK1PNP | |
| Phosphoric Acid SCHEMBL20856962 | 0.91 | EIF4E (0.46) | GDACYP3A4PMP22MAPK1PNP | |
| Pyridine SCHEMBL28098163 | 0.90 | GDA (0.41) | GDACYP3A4PMP22MAPK1PNP | |
| SCHEMBL23365318 | 0.89 | ADORA2A (0.43) | GDACYP3A4PMP22MAPK1PNP | |
| SCHEMBL6528880 | 0.87 | HSD17B10 (0.41) | GDACYP3A4PMP22MAPK1PNP | |
| Guanine SCHEMBL21840391 | 0.87 | PNP (0.68) | GDACYP3A4PMP22MAPK1PNP | |
| SCHEMBL19461404 | 0.86 | PNP (0.47) | PNPALDH1A1MAPTTHRBKDM4E | |
| Guanine SCHEMBL21840390 | 0.85 | PNP (0.43) | GDACYP3A4PMP22MAPK1PNP | |
| Triphosphate SCHEMBL28768402 | 0.85 | POLB (0.51) | CYP3A4PMP22MAPK1PNPEIF4E | |
| Beta-Alanine SCHEMBL23300588 | 0.85 | AKR1B1 (0.41) | GDACYP3A4PMP22MAPK1PNP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 45415 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747386-A1 | DOUBLE-STRANDED OLIGONUCLEOTIDE AGENTS AND USES THEREOF | Bisirna Therapeutics Pte. Ltd. (SG) | 2026-05-27 | — | — | EP | claimed |
| US-12637489-B2 | Silicon containing modified nucleotide analogs | Singular Genomics Systems, Inc. (US) | 2026-05-26 | — | — | US | claimed |
| WO-2026107204-A1 | METHODS FOR ANALYZING LOW-DEPTH GENOME SEQUENCING DATA TO DETECT MINIMAL RESIDUAL DISEASE | GUARDANT HEALTH, INC. (US) | 2026-05-21 | — | — | WO | claimed |
| WO-2026106497-A2 | FUNCTIONALIZED CIRCULAR RNA AND METHODS AND INTERMEDIATES FOR THEIR PRODUCTION | SIEĆ BADAWCZA ŁUKASIEWICZ – PORT POLSKI OSRODEK ROZWOJU TECHNOLOGII (PL) | 2026-05-21 | — | — | WO | claimed |
| US-12630827-B2 | Antisense oligonucleotides targeting SCN2A for the treatment of SCN1A encephalopathies | ROGCON, INC. (US) | 2026-05-19 | — | — | US | claimed |
| US-12630851-B2 | Polynucleotide modification methods | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2026-05-19 | — | — | US | claimed |
| US-20260125686-A1 | COMPOSITIONS AND METHODS FOR MODULATION OF CFTR | CYSTIC FIBROSIS FOUND (US) | 2026-05-07 | — | — | US | claimed |
| EP-4735040-A1 | OPHTHALMIC VISCOELASTIC DEVICE AND KIT FOR USE IN EYE SURGERY | Carl Zeiss Meditec AG (DE) | 2026-05-06 | — | — | EP | claimed |
| WO-2026090123-A1 | METHODS AND COMPOSITIONS FOR MANAGING PESTS | UOVO INTERNATIONAL LLC (US) | 2026-04-30 | — | — | WO | claimed |
| WO-2026088246-A1 | METHOD FOR PRODUCING LOW-MOLECULAR-WEIGHT COMPOUND | ＮＴＴ株式会社 | 2026-04-30 | — | — | WO | claimed |
| WO-2001070776-A2 | NIMR COMPOSITIONS AND THEIR METHODS OF USE | TRUSTEES OF TUFTS COLLEGE (US) | 2001-09-27 | — | — | WO | claimed |
| EP-1117838-A1 | A METHOD FOR ANALYZING POLYNUCLEOTIDES | Variagenics, Inc. (US) | 2001-07-25 | — | — | EP | claimed |
| CN-1261373-A | Compositions and methods for activating genes of interest | CHARLES ALLEN BLACK JR (US) | 2000-07-26 | — | — | CN | claimed |
| WO-2000033084-A2 | ARRAYS OF ORGANIC COMPOUNDS ATTACHED TO SURFACES | SYNTRIX BIOCHIP, INC. (US) | 2000-06-08 | — | — | WO | claimed |
| EP-0993468-A1 | COMPOSITIONS AND METHODS FOR ACTIVATING GENES OF INTEREST | Black, Charles Allen Jr. (US) | 2000-04-19 | — | — | EP | claimed |
| WO-2000018967-A1 | A METHOD FOR ANALYZING POLYNUCLEOTIDES | VARIAGENICS, INC. (US) | 2000-04-06 | — | — | WO | claimed |
| US-5998596-A | Inhibition of protein kinase activity by aptameric action of oligonucleotides | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-12-07 | — | — | US | claimed |
| WO-1998042723-A9 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC DISORDERS | — | 1999-03-04 | — | — | WO | claimed |
| EP-0540693-B1 | THE REDUCTION OF NON-SPECIFIC AMPLIFICATION DURING $i(IN VITRO) NUCLEIC ACID AMPLIFICATION USING MODIFIED NUCLEIC ACID BASES | HOFFMANN LA ROCHE (CH) | 1999-01-20 | — | — | EP | claimed |
| WO-1998058944-A1 | COMPOSITIONS AND METHODS FOR ACTIVATING GENES OF INTEREST | BLACK CHARLES ALLEN JR (US) | 1998-12-30 | — | — | WO | claimed |